Impact of timing strategy of LIGHT, a new TNF superfamily on immune platform induced by HSV-1 gB DNA vaccine

Cytokine

Volumn 50, Issue 1, 2010, Pages 99-103

  Pouyanfard, Somayeh ^a   Bamdad, Taravat ^a   Parsania, Masoud ^b   Hashemi, Hamidreza ^a   Mohammadi, Masumeh Gorgian ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

gB DNA vaccine; HSV 1; Immune response; LIGHT; Timing

Indexed keywords

DNA VACCINE; GLYCOPROTEIN B; GRANZYME B; HERPES SIMPLEX VACCINE; HERPESVIRUS ENTRY MEDIATOR LIGAND; PLASMID DNA;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY SPECIFICITY; FEMALE; GRANZYMES; HELA CELLS; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 1; MUS;

EID: 77049116228     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.12.012     Document Type: Article

References (39)

1. Kutzler M.A., and Weiner D.B. Developing DNA vaccines that call to dendritic cells. J Clin Invest 114 9 (2004) 1334-1342
2. Sozzani S., Allavena P., Vecchi A., and Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66 1 (1999) 1-9
3. Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.L., et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8 1 (1998) 21-30
4. Rooney I.A., Butrovich K.D., Glass A.A., Borboroglu S., Benedict C.A., Whitbeck J.C., et al. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 275 19 (2000) 14307-14315
5. Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.F., et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell mediated allogeneic T cell response. J Immunol 164 8 (2000) 4105-4110
6. Tamada K., Shimozaki K., Chapoval A.I., Zhu G., Sica G., Flies D., et al. Modulation of T-cellmediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 6 3 (2000) 283-289
7. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 2 (2002) 116-126
8. Bertram E.M., Dawicki W., and Watts T.H. Role of T cell costimulation in anti-viral immunity. Semin Immunol 16 3 (2004) 185-196
9. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23 (2005) 23-68
10. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
11. Harrop J.A., Reddy M., Dede K., Brigham-Burke M., Lyn S., Tan K.B., et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 161 4 (1998) 1786-1794
12. Shaikh R.B., Santee S., Granger S.W., Butrovich K., Cheung T., Kronenberg M., et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167 11 (2001) 6330-6337
13. Wang J., Lo J.C., Foster A., Yu P., Chen H.M., Wang Y., et al. The regulation of T cell homeostasis and autoimmunity by T cell derived LIGHT. J Clin Invest 108 12 (2001) 1771-1780
14. Wang J., and Fu Y.X. The role of LIGHT in T cell-mediated immunity. Immunol Res 30 2 (2004) 201-214
15. Yu P., Lee Y., Liu W., Chin R.K., Wang J., Wang Y., et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 5 2 (2004) 123-124
16. Zou G.M., Martinson J., Hu W.Y., Tam Y., and Klingemann H.G. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients. Cancer Immunol Immunother 53 8 (2004) 681-689
17. Zou G.M., and Hu W.Y. LIGHT regulates CD86 expression on dendritic cells through NF-κB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol 205 3 (2005) 437-443
18. Morel Y., Truneh A., Costello R.T., and Olive D. LIGHT, a new TNF superfamily member, is essential for memory T helper cell-mediated activation of dendritic cells. Eur J Immunol 33 11 (2003) 3213-3219
19. Bamdad T., Roostaee M.H., Sadeghizadeh M., Mahboudi F., Kazemnejad A., and Soleimanjahi H. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B. Folia Biol (Praha) 51 4 (2005) 109-113
20. Misawa K., Nosaka T., Kojima T., Hirai M., and Kitamura T. Molecular cloning and characterization of a mouse homolog of human TNFSF14, a member of the TNF superfamily. Cytogenet Cell Genet 89 1-2 (2000) 89-91
21. Eing B.R., Kühn J.E., and Braun R.W. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins. J Med Virol 27 1 (1989) 59-65
22. Fuller A.O., and Spear P.G. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc Natl Acad Sci USA 84 15 (1987) 5454-5458
23. Gompels U., and Minson A. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153 2 (1986) 230-247
24. Minson A.C., Hodgman T.C., Digard P., Hancock D.C., Bell S.E., and Buckmaster E.A. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralisation. J Gen Virol 67 Pt. 6 (1986) 1001-1013
25. Blacklaws B.A., Krishna S., Minson A.C., and Nash A.A. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177 2 (1990) 727-736
26. Fló J. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice. Vaccine 21 11-12 (2003) 1239-1245
27. Kriesel J.D., Spruance S.L., Daynes R.A., and Araneo B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect Dis 173 3 (1996) 536-541
28. Fló J., Beatriz Perez A., Tisminetzky S., and Baralle F. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the codelivery of the GM-CSF gene. Vaccine 18 28 (2000) 3242-3253
29. Shroff K.E., Marcucci-Borges L.A., de Bruin S.J., Winter L.A., Tiberio L., Pachuk C., et al. Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration. Vaccine 18 3-4 (1999) 222-230
30. Caselli E., Balboni P.G., Incorvaia C., Argnani R., Parmeggiani F., Cassai E., et al. Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection. Vaccine 19 9-10 (2000) 1225-1231
31. Domingo C., Gadea I., Pardeiro M., Castilla C., Fernández S., Fernández-Clua M.A., et al. Immunological properties of a DNA plasmid encoding a chimeric protein of Herpes simplex virus type 2 glycoprotein B and glycoprotein D. Vaccine 21 25-26 (2003) 3565-3574
32. Griffiths G.M. The cell biology of CTL killing. Curr Opin Immunol 7 3 (1995) 343-348
33. Rininsland F.H., Helms T., Asaad R.J., Boehm B.O., and Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 240 1-2 (2000) 143-155
34. Gorgian Mohammadi M., Bamdad T., Parsania M., Hashemi H.R., and Pouyanfard S. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity. Iran J Immunol 6 1 (2009) 22-27
35. Ewen C., Kane K.P., Shostak I., Griebel P.J., Bertram E.M., Watts T.H., et al. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J Immunol Methods 276 1-2 (2003) 89-101
36. Ewen C.L., Rong J., Kokaji A.I., Bleackley R.C., and Kane K.P. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay. J Immunol Methods 308 1-2 (2006) 156-166
37. Zhang Y., Jiang W., Fan Y., Wen J., Hao W., and Qian M. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. J Virol Methods 153 2 (2008) 142-148
38. Kusakabe K., Xin K.Q., Katoh H., Sumino K., Hagiwara E., Kawamoto S., et al. The timing of GMCSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1 specific DNA vaccine. J Immunol 164 6 (2000) 3102-3111
39. Hartoonian C., Ebtekar M., Soleimanjahi H., Karami A., Mahdavi M., Rastgoo N., et al. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine. Cytokine 46 1 (2009) 43-50